SPRAVATO®
Emerge Ketamine strives to keep ketamine treatment as affordable and accessible to as many people as possible.
Spravato is covered by the following insurance providers:
- Aetna
- Cigna
- BCBS of Mass
- Humana
SPRAVATO® Patient Brochure
If you struggle with treatment-resistant depression, there are other options. SPRAVATO® is a prescription medicine,
used along with an antidepressant taken by mouth to treat adults with treatment-resistant depression (TRD).
Is SPRAVATO® Covered by Insurance?
Most insurance plans do cover Spravato. Emerge Ketamine does not bill your insurance company directly. Instead, patients are given a ‘super bill’ that they can send to their insurer for reimbursement.
Is SPRAVATO® FDA Approved?
Spravato was FDA approved for treatment resistant depression in 2019. In 2020 it was approved for use in adults with Major Depressive Disorder and Acute Suicidal Ideation.
Spravato is the only FDA-approved nasal spray for
adult patients with two forms of challenging-to-treat
major depressive disorder (MDD).
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Contact Us for Pricing
During a free telemedicine evaluation, we will answer any questions you have about IV ketamine therapy, and assess how it can enhance your healing.
We Also Offer Other Ketamine Treatments
In-Home Ketamine Infusions
$700/infusion
Ketamine Treatments at Emerge
$500/infusion
Contact Emerge Ketamine
Call or Text
Email Us
Visit Us
100 Tradecenter Dr.
Suite G700
Office 813
Woburn, MA 01801-1851
Get directions »